126 related articles for article (PubMed ID: 11507083)
21. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
22. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
23. The role of stem cell factor and of alternative c-kit gene products in the establishment, maintenance and function of germ cells.
Sette C; Dolci S; Geremia R; Rossi P
Int J Dev Biol; 2000; 44(6):599-608. PubMed ID: 11061423
[TBL] [Abstract][Full Text] [Related]
24. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Attoub S; Rivat C; Rodrigues S; Van Bocxlaer S; Bedin M; Bruyneel E; Louvet C; Kornprobst M; André T; Mareel M; Mester J; Gespach C
Cancer Res; 2002 Sep; 62(17):4879-83. PubMed ID: 12208734
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia.
Cole SR; Aylett GW; Harvey NL; Cambareri AC; Ashman LK
Leukemia; 1996 Feb; 10(2):288-96. PubMed ID: 8637238
[TBL] [Abstract][Full Text] [Related]
26. Implication of stem cell factor in the proliferation of choroidal melanocytes.
Mouriaux F; Chahud F; Maurage CA; Malecaze F; Labalette P
Exp Eye Res; 2001 Aug; 73(2):151-7. PubMed ID: 11446765
[TBL] [Abstract][Full Text] [Related]
27. Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts.
Pizzolo G; Rigo A; Zanotti R; Vinante F; Vincenzi C; Cassatella M; Carra G; Castaman G; Chilosi M; Semenzato G
Leukemia; 1993 Mar; 7(3):418-25. PubMed ID: 8445947
[TBL] [Abstract][Full Text] [Related]
28. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
Woźniak J; Kopeć-Szlezak J
Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
[TBL] [Abstract][Full Text] [Related]
29. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
Lilly AJ; Khanim FL; Hayden RE; Luong QT; Drayson MT; Bunce CM
Cancer Res; 2011 Feb; 71(3):1177-86. PubMed ID: 21169412
[TBL] [Abstract][Full Text] [Related]
30. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
Fei J; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
[TBL] [Abstract][Full Text] [Related]
31. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
Contractor R; Samudio IJ; Estrov Z; Harris D; McCubrey JA; Safe SH; Andreeff M; Konopleva M
Cancer Res; 2005 Apr; 65(7):2890-8. PubMed ID: 15805291
[TBL] [Abstract][Full Text] [Related]
32. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
Bieker R; Padró T; Kramer J; Steins M; Kessler T; Retzlaff S; Herrera F; Kienast J; Berdel WE; Mesters RM
Cancer Res; 2003 Nov; 63(21):7241-6. PubMed ID: 14612519
[TBL] [Abstract][Full Text] [Related]
34. Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement.
Caruana G; Cambareri AC; Gonda TJ; Ashman LK
Oncogene; 1998 Jan; 16(2):179-90. PubMed ID: 9464535
[TBL] [Abstract][Full Text] [Related]
35. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
Pedersen M; Rönnstrand L; Sun J
Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
[TBL] [Abstract][Full Text] [Related]
36. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
[TBL] [Abstract][Full Text] [Related]
37. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
38. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J
Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
[TBL] [Abstract][Full Text] [Related]
39. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
40. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
Guo Y; Bian S; Luo M
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
